988 related articles for article (PubMed ID: 9748718)
1. Appropriate mammalian expression systems for biopharmaceuticals.
Werner RG; Noé W; Kopp K; Schlüter M
Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
[TBL] [Abstract][Full Text] [Related]
2. Monitoring the glycosylation pattern of recombinant interferon-omega with high-pH anion-exchange chromatography and capillary electrophoresis.
Kopp K; Schlüter M; Werner RG
Arzneimittelforschung; 1996 Dec; 46(12):1191-6. PubMed ID: 9006797
[TBL] [Abstract][Full Text] [Related]
3. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
[TBL] [Abstract][Full Text] [Related]
4. Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.
Gawlitzek M; Estacio M; Fürch T; Kiss R
Biotechnol Bioeng; 2009 Aug; 103(6):1164-75. PubMed ID: 19418565
[TBL] [Abstract][Full Text] [Related]
5. Effects of fermentation on product consistency.
Lubiniecki AS; Anumula K; Callaway J; L'Italien J; Oka M; Okita B; Wasserman G; Zabriskie D; Arathoon R; Builder S
Dev Biol Stand; 1992; 76():105-15. PubMed ID: 1478331
[TBL] [Abstract][Full Text] [Related]
6. Innovative and economic potential of mammalian cell culture.
Werner RG
Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
[TBL] [Abstract][Full Text] [Related]
7. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production.
Daly R; Hearn MT
J Mol Recognit; 2005; 18(2):119-38. PubMed ID: 15565717
[TBL] [Abstract][Full Text] [Related]
8. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
[TBL] [Abstract][Full Text] [Related]
9. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
11. Isolation, primary structure characterization and identification of the glycosylation pattern of recombinant goldfish neurolin, a neuronal cell adhesion protein.
Denzinger T; Diekmann H; Bruns K; Laessing U; Stuermer CA; Przybylski M
J Mass Spectrom; 1999 Apr; 34(4):435-46. PubMed ID: 10226368
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational processing of recombinant human interferon-gamma in animal expression systems.
James DC; Goldman MH; Hoare M; Jenkins N; Oliver RW; Green BN; Freedman RB
Protein Sci; 1996 Feb; 5(2):331-40. PubMed ID: 8745411
[TBL] [Abstract][Full Text] [Related]
13. Purification of the extracellular domain of the membrane protein GlialCAM expressed in HEK and CHO cells and comparison of the glycosylation.
Gaudry JP; Arod C; Sauvage C; Busso S; Dupraz P; Pankiewicz R; Antonsson B
Protein Expr Purif; 2008 Mar; 58(1):94-102. PubMed ID: 18082421
[TBL] [Abstract][Full Text] [Related]
14. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
15. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
16. The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies.
Wagner-Rousset E; Bednarczyk A; Bussat MC; Colas O; Corvaïa N; Schaeffer C; Van Dorsselaer A; Beck A
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):23-37. PubMed ID: 18672411
[TBL] [Abstract][Full Text] [Related]
17. Mammalian cell cultures. Part II: Genetic engineering, protein glycosylation, fermentation and process control.
Werner RG; Noé W
Arzneimittelforschung; 1993 Nov; 43(11):1242-9. PubMed ID: 8292072
[TBL] [Abstract][Full Text] [Related]
18. High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene.
Running Deer J; Allison DS
Biotechnol Prog; 2004; 20(3):880-9. PubMed ID: 15176895
[TBL] [Abstract][Full Text] [Related]
19. Control of culture environment for improved polyethylenimine-mediated transient production of recombinant monoclonal antibodies by CHO cells.
Galbraith DJ; Tait AS; Racher AJ; Birch JR; James DC
Biotechnol Prog; 2006; 22(3):753-62. PubMed ID: 16739959
[TBL] [Abstract][Full Text] [Related]
20. Analysis of site-specific glycosylation in recombinant human follistatin expressed in Chinese hamster ovary cells.
Hyuga M; Itoh S; Kawasaki N; Ohta M; Ishii A; Hyuga S; Hayakawa T
Biologicals; 2004 Jun; 32(2):70-7. PubMed ID: 15454184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
